What's new

Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 13, Status: Authorised

May 6, 2025 - 14:29
 0
Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Trump administration asks judge to toss suit restricting access to abortion medi...

Next Article

Growing complexity and more hybrid projects: mitigating risk in solar offtake ag...

Related Posts

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

SPOR and XEVMPD status update webinar, Broadcast, from 9 April 2025, 10:00 (CEST) to 9 April 2025, 12:30 (CEST)

SPOR and XEVMPD status update webinar, Broadcast, from ...

Apr 29, 2025  0

Opzelura

Opzelura

Apr 24, 2025  0